Patent · US Expired

Treatment of lipid metabolic disorders using 5-(1,2-dithiolan-3-yl) valeric acid (&agr;-lipoic acid) or its physiologically compatible salts

US6518300B2 · kind B2 · utility

1Cited by

0References

1Claims

0Family size

Assignees

BiRD Berolina innovative Research and Development GmbH · DE
Esparma GmbH · DE

Inventors

Rudolf-Giesbert Alken · Oderberg, DE
Dieter Koegst · Osterweddingen, DE
Gerhard Fries · Gommern, DE

Key dates

Filing date	Oct 9, 2001
Grant date	Feb 11, 2003
Priority date	—
Expiry date	Oct 9, 2021

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P9/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Lipid metabolic disorders, such as hyperlipidemia or hyperlipoproteinemia can be treated by administering to an afflicted individual an effective amount of 5-(1,2-dithiolan-3-yl) valeric acid (&agr;-lipoic acid) or one of its physiologically acceptable salts. Pharmaceutical compositions containing (&agr;-lipoic acid) and methods for making such compositions also are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.